WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 21011-21027

  Chen, Juan ^a,b   Yin, Jiye ^a,b   Li, Xiangping ^a,b   Wang, Ying ^b   Zheng, Yi ^a,b   Qian, Chenyue ^a,b   Xiao, Ling ^a,b   Zou, Ting ^a,b   Wang, Zhan ^a   Liu, Junyan ^c   Zhang, Wei ^a,b   Zhou, Honghao ^a,b   Liu, Zhaoqian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Central South University   (China)

Author keywords

Chemotherapy toxicity; Genetic polymorphism; Lung cancer; WISP1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; ETOPOSIDE; GEMCITABINE; IRINOTECAN; NAVELBINE; PACLITAXEL; PLATINUM; ANTINEOPLASTIC AGENT; CCN PROTEIN; ONCOPROTEIN; WISP1 PROTEIN, HUMAN;

ADULT; ALLELE; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CREATININE CLEARANCE; DIARRHEA; DNA EXTRACTION; FEMALE; GASTROINTESTINAL TOXICITY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; NEUTROPHIL COUNT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VOMITING; WISP1 GENE; DRUG EFFECTS; GENETICS; LUNG; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTINEOPLASTIC AGENTS; CCN INTERCELLULAR SIGNALING PROTEINS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLATINUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS;

EID: 84910122280     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151121011     Document Type: Article

References (36)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013. CA Cancer J Clin. 2013, 63, 11-30.
2. Spira, A.; Ettinger, D.S. Multidisciplinary management of lung cancer. N. Engl. J. Med. 2004, 350, 379-392.
3. Akiri, G.; Cherian, M.M.; Vijayakumar, S.; Liu, G.; Bafico, A.; Aaronson, S.A. Wnt pathway aberrations including autocrine wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene 2009, 28, 2163-2172.
4. Paul, I.; Chacko, A.D.; Stasik, I.; Busacca, S.; Crawford, N.; McCoy, F.; McTavish, N.; Wilson, B.; Barr, M.; O’Byrne, K.J., et al. Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer. Cell Death Dis. 2012, 3, e449.
5. Olaussen, K.A.; Planchard, D.; Adam, J.; Soria, J.C. DNA repair pathways and non-small cell lung cancer: Clinical perspectives. Bull. Cancer 2011, 98, 305-322.
6. Lee, S.Y.; Kang, H.G.; Yoo, S.S.; Kang, Y.R.; Choi, Y.Y.; Lee, W.K.; Choi, J.E.; Jeon, H.S.; Shin, K.M.; Oh, I.J., et al. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy. Lung Cancer 2013, 82, 330-339.
7. Kim, S.H.; Lee, G.W.; Lee, M.J.; Cho, Y.J.; Jeong, Y.Y.; Kim, H.C.; Lee, J.D.; Hwang, Y.S.; Kim, I.S.; Lee, S., et al. Clinical significance of ercc2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy. Lung Cancer 2012, 77, 578-584.
8. Xu, L.; Corcoran, R.B.; Welsh, J.W.; Pennica, D.; Levine, A.J. Wisp-1 is a wnt-1-and beta-catenin-responsive oncogene. Genes Dev. 2000, 14, 585-595.
9. Chen, P.P.; Li, W.J.; Wang, Y.; Zhao, S.; Li, D.Y.; Feng, L.Y.; Shi, X.L.; Koeffler, H.P.; Tong, X.J.; Xie, D. Expression of cyr61, ctgf, and wisp-1 correlates with clinical features of lung cancer. PLoS One 2007, 2, e534.
10. Li, H.H.; Li, Q.; Liu, P.; Liu, Y.; Li, J.; Wasserloos, K.; Chao, W.; You, M.; Oury, T.D.; Chhinder, S., et al. Wnt1-inducible signaling pathway protein 1 contributes to ventilator-induced lung injury. Am. J. Respir. Cell Mol. Biol. 2012, 47, 528-535.
11. Berschneider, B.; Konigshoff, M. Wnt1 inducible signaling pathway protein 1 (wisp1): A novel mediator linking development and disease. Int. J. Biochem. Cell Biol. 2011, 43, 306-309.
12. Watari, H.; Xiong, Y.; Hassan, M.K.; Sakuragi, N. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype. Gynecol. Oncol. 2009, 112, 229-234.
13. Pennica, D.; Swanson, T.A.; Welsh, J.W.; Roy, M.A.; Lawrence, D.A.; Lee, J.; Brush, J.; Taneyhill, L.A.; Deuel, B.; Lew, M., et al. Wisp genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl Acad. Sci. USA 1998, 95, 14717-14722.
14. Davies, S.R.; Watkins, G.; Mansel, R.E.; Jiang, W.G. Differential expression and prognostic implications of the ccn family members wisp-1, wisp-2, and wisp-3 in human breast cancer. Ann. Surg. Oncol. 2007, 14, 1909-1918.
15. Venkatesan, B.; Prabhu, S.D.; Venkatachalam, K.; Mummidi, S.; Valente, A.J.; Clark, R.A.; Delafontaine, P.; Chandrasekar, B. Wnt1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell. Signal. 2010, 22, 809-820.
16. Inkson, C.A.; Ono, M.; Bi, Y.; Kuznetsov, S.A.; Fisher, L.W.; Young, M.F. The potential functional interaction of biglycan and wisp-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs 2009, 189, 153-157.
17. Venkatachalam, K.; Venkatesan, B.; Valente, A.J.; Melby, P.C.; Nandish, S.; Reusch, J.E.; Clark, R.A.; Chandrasekar, B. Wisp1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (tnf-alpha)-stimulated cardiac fibroblast proliferation but inhibits tnf-alpha-induced cardiomyocyte death. J. Biol. Chem. 2009, 284, 14414-14427.
18. Sharma, S.; Tantisira, K.; Carey, V.; Murphy, A.J.; Lasky-Su, J.; Celedon, J.C.; Lazarus, R.; Klanderman, B.; Rogers, A.; Soto-Quiros, M., et al. A role for wnt signaling genes in the pathogenesis of impaired lung function in asthma. Am. J. Respir. Crit. Care Med. 2010, 181, 328-336.
19. Chen, J.; Yin, J.Y.; Li, X.P. Clin. Lung Cancer, submitted for publication, 2014.
20. Lien, W.H.; Fuchs, E. Wnt some lose some: Transcriptional governance of stem cells by wnt/beta-catenin signaling. Genes Dev. 2014, 28, 1517-1532.
21. Novo, M.C.; Osugui, L.; Dos Reis, V.O.; Longo-Maugeri, I.M.; Mariano, M.; Popi, A.F. Blockage of wnt/beta-catenin signaling by quercetin reduces survival and proliferation of b-1 cells in vitro. Immunobiology 2014, doi:10.1016/j.imbio.2014.09.001.
22. Salaroli, R.; Ronchi, A.; Buttarelli, F.R.; Cortesi, F.; Marchese, V.; Bella, E.D.; Renna, C.; Baldi, C.; Giangaspero, F.; Cenacchi, G. Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma. J. Neurooncol. 2014, doi:10.1007/s11060-014-1621-0.
23. Yuan, R.; Wang, K.; Hu, J.; Yan, C.; Li, M.; Yu, X.; Liu, X.; Lei, J.; Guo, W.; Wu, L., et al. Ubiquitin-like protein fat10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying beta-catenin degradation. Cancer Res. 2014, doi:10.1158/0008-5472.CAN-14-0284.
24. Lee, K.B.; Ye, S.; Park, M.H.; Park, B.H.; Lee, J.S.; Kim, S.M. P63-mediated activation of the beta-catenin/c-myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis. Cancer Lett. 2014, 353, 124-132.
25. Yamada, Y.; Ando, F.; Shimokata, H. Association of polymorphisms of sorbs1, gck and wisp1 with hypertension in community-dwelling japanese individuals. Hypertens. Res. 2009, 32, 325-331.
26. Urano, T.; Narusawa, K.; Shiraki, M.; Usui, T.; Sasaki, N.; Hosoi, T.; Ouchi, Y.; Nakamura, T.; Inoue, S. Association of a single nucleotide polymorphism in the wisp1 gene with spinal osteoarthritis in postmenopausal japanese women. J. Bone Miner. Metab. 2007, 25, 253-258.
27. Baralle, D.; Baralle, M. Splicing in action: Assessing disease causing sequence changes. J. Med. Genet. 2005, 42, 737-748.
28. Buratti, E.; Baralle, M.; Baralle, F.E. Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res. 2006, 34, 3494-3510.
29. Matoulkova, E.; Michalova, E.; Vojtesek, B.; Hrstka, R. The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol. 2012, 9, 563-576.
30. Zamorano, J.; Erdine, S.; Lopez, A.P.; Kim, J.H.; Al Khadra, A.; Westergaard, M.; Sutradhar, S.; Yunis, C. Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: The crucial study. Postgrad. Med. 2010, 122, 7-15.
31. Klett, C.P.; Bonner, T.I. Identification and characterization of the rat m1 muscarinic receptor promoter. J. Neurochem. 1999, 72, 900-909.
32. Xu, X.; Duan, L.; Zhou, B.; Ma, R.; Zhou, H.; Liu, Z. Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in chinese non-small cell lung carcinoma patients. Clin. Exp. Pharmacol. Physiol. 2012, 39, 786-792.
33. Xu, X.; Han, L.; Duan, L.; Zhao, Y.; Yang, H.; Zhou, B.; Ma, R.; Yuan, R.; Zhou, H.; Liu, Z. Association between eif3alpha polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients. Br. J. Clin. Pharmacol. 2013, 75, 516-523.
34. Xu, X.; Han, L.; Yang, H.; Duan, L.; Zhou, B.; Zhao, Y.; Qu, J.; Ma, R.; Zhou, H.; Liu, Z. The a/g allele of eif3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients. Lung Cancer 2013, 79, 65-72.
35. Xu, X.; Ren, H.; Zhou, B.; Zhao, Y.; Yuan, R.; Ma, R.; Zhou, H.; Liu, Z. Prediction of copper transport protein 1 (ctr1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (nsclc) patients. Lung Cancer 2012, 77, 438-442.
36. Purcell, S.; Neale, B.; Todd-Brown, K.; Thomas, L.; Ferreira, M.A.; Bender, D.; Maller, J.; Sklar, P.; de Bakker, P.I.; Daly, M.J., et al. Plink: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81, 559-575.